CS219885B2 - Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide - Google Patents
Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide Download PDFInfo
- Publication number
- CS219885B2 CS219885B2 CS774811A CS481177A CS219885B2 CS 219885 B2 CS219885 B2 CS 219885B2 CS 774811 A CS774811 A CS 774811A CS 481177 A CS481177 A CS 481177A CS 219885 B2 CS219885 B2 CS 219885B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dimethoxy
- allyl
- compound
- group
- sulfamoylbenzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7622180A FR2358892A1 (fr) | 1976-07-19 | 1976-07-19 | N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS219885B2 true CS219885B2 (en) | 1983-03-25 |
Family
ID=9175947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS774811A CS219885B2 (en) | 1976-07-19 | 1977-07-19 | Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide |
Country Status (38)
Country | Link |
---|---|
US (1) | US4499019A (fi) |
JP (1) | JPS5338631A (fi) |
AR (1) | AR214330A1 (fi) |
AT (1) | AT365570B (fi) |
AU (1) | AU509291B2 (fi) |
BE (1) | BE856289A (fi) |
CH (1) | CH627162A5 (fi) |
CS (1) | CS219885B2 (fi) |
CY (1) | CY1036A (fi) |
DD (2) | DD137670A5 (fi) |
DK (1) | DK156646C (fi) |
EG (1) | EG12911A (fi) |
ES (1) | ES460621A1 (fi) |
FI (1) | FI67213C (fi) |
FR (1) | FR2358892A1 (fi) |
GB (1) | GB1539319A (fi) |
GR (1) | GR60836B (fi) |
HK (1) | HK17880A (fi) |
HU (1) | HU174981B (fi) |
IE (1) | IE46171B1 (fi) |
IL (1) | IL52547A (fi) |
IN (1) | IN146993B (fi) |
LU (1) | LU77782A1 (fi) |
MC (1) | MC1153A1 (fi) |
MX (1) | MX4711E (fi) |
NL (1) | NL174347C (fi) |
NO (1) | NO146598C (fi) |
NZ (1) | NZ184634A (fi) |
OA (1) | OA05704A (fi) |
PH (1) | PH12838A (fi) |
PL (1) | PL104244B1 (fi) |
PT (1) | PT66819B (fi) |
RO (1) | RO71691A (fi) |
SE (1) | SE425243B (fi) |
SU (1) | SU695556A3 (fi) |
YU (1) | YU40677B (fi) |
ZA (1) | ZA774256B (fi) |
ZM (1) | ZM5477A1 (fi) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2438650A1 (fr) * | 1978-10-11 | 1980-05-09 | Ile De France | N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire |
JPS5639431A (en) * | 1979-09-06 | 1981-04-15 | Susumu Yagyu | Colorimeter having two-light pass length and two-wave length |
FR2478093A1 (fr) * | 1980-03-12 | 1981-09-18 | Ile De France | Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue) |
FR2550447B1 (fr) * | 1983-08-10 | 1986-01-17 | Ile De France | Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire |
FR2584605B1 (fr) * | 1985-07-15 | 1988-06-17 | Ile De France | Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson |
US7645750B2 (en) * | 2006-12-13 | 2010-01-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Method of treating symptoms of hormonal variations |
US8420624B2 (en) * | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
CN105481733A (zh) * | 2015-12-30 | 2016-04-13 | 苏州诚和医药化学有限公司 | 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法 |
-
1976
- 1976-07-19 FR FR7622180A patent/FR2358892A1/fr active Granted
-
1977
- 1977-05-24 CY CY1036A patent/CY1036A/xx unknown
- 1977-05-24 GB GB21883/77A patent/GB1539319A/en not_active Expired
- 1977-06-30 BE BE1008238A patent/BE856289A/xx not_active IP Right Cessation
- 1977-07-05 OA OA56219A patent/OA05704A/xx unknown
- 1977-07-05 MC MC771249A patent/MC1153A1/xx unknown
- 1977-07-08 PH PH19975A patent/PH12838A/en unknown
- 1977-07-08 ZM ZM54/77A patent/ZM5477A1/xx unknown
- 1977-07-11 AR AR268387A patent/AR214330A1/es active
- 1977-07-11 EG EG413/77A patent/EG12911A/xx active
- 1977-07-11 ES ES460621A patent/ES460621A1/es not_active Expired
- 1977-07-12 GR GR53944A patent/GR60836B/el unknown
- 1977-07-13 CH CH867977A patent/CH627162A5/fr not_active IP Right Cessation
- 1977-07-13 YU YU1739/77A patent/YU40677B/xx unknown
- 1977-07-13 NZ NZ184634A patent/NZ184634A/xx unknown
- 1977-07-14 SE SE7708176A patent/SE425243B/xx not_active IP Right Cessation
- 1977-07-14 AU AU27026/77A patent/AU509291B2/en not_active Expired
- 1977-07-15 PT PT66819A patent/PT66819B/pt unknown
- 1977-07-15 AT AT0511677A patent/AT365570B/de not_active IP Right Cessation
- 1977-07-15 LU LU77782A patent/LU77782A1/xx unknown
- 1977-07-15 DD DD77207969A patent/DD137670A5/xx not_active IP Right Cessation
- 1977-07-15 MX MX775905U patent/MX4711E/es unknown
- 1977-07-15 JP JP8552977A patent/JPS5338631A/ja active Granted
- 1977-07-15 DD DD7700200091A patent/DD132492A5/xx not_active IP Right Cessation
- 1977-07-15 NO NO772530A patent/NO146598C/no unknown
- 1977-07-15 HU HU77SO1193A patent/HU174981B/hu unknown
- 1977-07-15 IE IE1482/77A patent/IE46171B1/en not_active IP Right Cessation
- 1977-07-18 NL NLAANVRAGE7707982,A patent/NL174347C/xx not_active IP Right Cessation
- 1977-07-18 IL IL52547A patent/IL52547A/xx unknown
- 1977-07-18 FI FI772214A patent/FI67213C/fi not_active IP Right Cessation
- 1977-07-18 DK DK326377A patent/DK156646C/da not_active IP Right Cessation
- 1977-07-18 PL PL1977199723A patent/PL104244B1/pl unknown
- 1977-07-19 SU SU772504152A patent/SU695556A3/ru active
- 1977-07-19 CS CS774811A patent/CS219885B2/cs unknown
- 1977-07-19 RO RO7791091A patent/RO71691A/ro unknown
- 1977-08-23 IN IN1318/CAL/77A patent/IN146993B/en unknown
-
1978
- 1978-05-12 ZA ZA00774256A patent/ZA774256B/xx unknown
-
1980
- 1980-04-03 HK HK178/80A patent/HK17880A/xx unknown
-
1983
- 1983-10-13 US US06/540,918 patent/US4499019A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE457081B (sv) | 1,2-diaminocyklobutan-3,4-dioner, foerfarande foer framstaellning av dessa, mellanprodukt och en farmaceutisk komposition | |
JPH0662568B2 (ja) | 新規化合物、その調製方法および筋肉弛緩剤としての使用 | |
EP0047923B1 (de) | Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
IE44280B1 (en) | 2,3-dihydro-imidazo/2,1-b-thiazole derivatives and process for their preparation | |
JPH0428269B2 (fi) | ||
CS219885B2 (en) | Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide | |
JPS62145049A (ja) | アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤 | |
US3265691A (en) | 1-benzyl-2-aminomethyl-5, 6-dialkoxybenzimidazoles | |
DE3233424A1 (de) | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung | |
HUT70174A (en) | New 3-phenyl-sulphonyl-3,7-diazabicyclo [3.3.1] nonane compounds and pharmaceutical compounds containing the same | |
EP0099122B1 (en) | Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity | |
PT100216B (pt) | N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem | |
JPS60158190A (ja) | ヒダントイン誘導体およびその製法ならびにそれを含有する医薬 | |
CS221527B2 (en) | Method of preparation of n-/1-methyl-2-pyrrolidinylmethyl/2,3-dimethoxy-5-methylsulphamoylbenzamide | |
SK278141B6 (en) | Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent | |
US3005818A (en) | 1-phenyl-2, 3-dimethyl-4-morpholino methyl pyrazolone-(5) compounds | |
IE45144B1 (en) | Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity | |
US3586675A (en) | Fused thiazines | |
DE2734270C2 (fi) | ||
JPS63227570A (ja) | イソキノリン誘導体 | |
CS208658B2 (en) | Method of makingthe derivatives of the 3-amino-17aaza-d-homo-5alfaandrostane | |
US4100287A (en) | Pyrimidine derivative | |
CS208131B2 (en) | Method of making the new derivatives of the 1,3-benzoxazine-2,4-dione | |
US4853415A (en) | 2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radiation sensitizers | |
US3468889A (en) | O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same |